This article explains key differences between FDA and EMA regulatory systems, focusing on approval processes, GMP inspection readiness, and compliance expectations. It also highlights data integrity compliance, pharmacovigilance requirements, and regulatory submission strategy for global pharmaceutical market authorization.
